Actively Recruiting

Phase 1
Age: 18Years - 65Years
All Genders
Healthy Volunteers
NCT07540910

A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Doses of EDP-978 in Healthy Adults

Led by Enanta Pharmaceuticals, Inc · Updated on 2026-04-21

98

Participants Needed

1

Research Sites

30 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This study is a randomized, double-blind, sponsor-open, placebo-controlled study. It will assess the safety, tolerability, pharmacokinetics and pharmacodynamics of orally administered single and multiple doses of EDP-978 in healthy adult subjects.

CONDITIONS

Official Title

A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Doses of EDP-978 in Healthy Adults

Who Can Participate

Age: 18Years - 65Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Signed informed consent document
  • Healthy male and female adults between 18 and 65 years of age, inclusive
Not Eligible

You will not qualify if you...

  • Clinically relevant illness or disease history
  • Infection with HIV, hepatitis B, hepatitis C at screening, or SARS-CoV-2 infection at Day -1 visit
  • Pregnant or nursing females
  • Febrile illness within 7 days before first dose or evidence of active infection
  • Positive urine drug screen at screening or Day -1
  • Current tobacco smokers or tobacco use within 3 months prior to screening
  • Conditions affecting drug absorption (e.g., gastrectomy, cholecystectomy)
  • History of regular alcohol consumption
  • Receipt of vaccines, investigational agents, or biological products within 28 days or 5 times the drug half-life before first dose

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

ICON Early Phase

San Antonio, Texas, United States, 78209

Actively Recruiting

Loading map...

Research Team

E

Enanta Pharmaceuticals, Inc

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

4

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here